Beurs gesloten -
OTC Markets
17:43:36 19-12-2023
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4,2
USD
|
-4,55%
|
|
-.--%
|
-.--%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
47.335
|
139.718
|
104.196
|
87.567
|
44.807
|
40.903
|
-
|
-
|
Bedrijfswaarde
1 |
46.226
|
129.700
|
96.434
|
82.021
|
40.354
|
33.600
|
33.103
|
31.765
|
K/w-verhouding
|
55,9
x
|
73,8
x
|
38,7
x
|
45
x
|
23,5
x
|
21,5
x
|
17,9
x
|
15,7
x
|
Dividendrendement
|
0,44%
|
0,19%
|
0,39%
|
0,52%
|
1,03%
|
0,99%
|
1,17%
|
1,19%
|
Marktkapitalisatie/omzet
|
16,9
x
|
43,8
x
|
20
x
|
12,4
x
|
6,07
x
|
5,15
x
|
4,54
x
|
3,99
x
|
Bedrijfswaarde/omzet
|
16,5
x
|
40,6
x
|
18,5
x
|
11,6
x
|
5,47
x
|
4,23
x
|
3,67
x
|
3,1
x
|
Bedrijfswaarde/EBITDA
|
40,8
x
|
56,2
x
|
25,2
x
|
27,7
x
|
13,7
x
|
11,8
x
|
10
x
|
8,24
x
|
Bedrijfswaarde/FCF
|
108
x
|
154
x
|
91,3
x
|
90
x
|
47,9
x
|
21,7
x
|
15,7
x
|
20,2
x
|
FCF Yield
|
0,93%
|
0,65%
|
1,1%
|
1,11%
|
2,09%
|
4,6%
|
6,38%
|
4,94%
|
Price to Book
|
11,2
x
|
8,75
x
|
6,15
x
|
4,67
x
|
2,28
x
|
1,89
x
|
1,74
x
|
1,59
x
|
Aantal aandelen (in duizenden)
|
749.557
|
872.509
|
860.729
|
864.949
|
866.366
|
861.497
|
-
|
-
|
Referentieprijs
2 |
63,15
|
161,6
|
127,8
|
104,8
|
54,97
|
50,82
|
50,82
|
50,82
|
Datum van publicatie
|
28/02/20
|
29/03/21
|
10/03/22
|
28/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
2.803
|
3.192
|
5.214
|
7.085
|
7.384
|
8.106
|
9.012
|
10.242
|
EBITDA
1 |
1.132
|
2.308
|
3.820
|
2.963
|
2.949
|
2.837
|
3.310
|
3.856
|
Bedrijfsresultaat (EBIT)
1 |
1.085
|
2.222
|
3.697
|
2.678
|
2.610
|
2.621
|
3.262
|
3.721
|
Operationele Marge
|
38,69%
|
69,62%
|
70,91%
|
37,8%
|
35,35%
|
32,34%
|
36,2%
|
36,33%
|
Resultaat voor belastingen (EBT)
1 |
1.089
|
2.219
|
3.690
|
2.595
|
2.490
|
2.539
|
3.061
|
2.967
|
Nettowinst (verlies)
1 |
841,6
|
1.750
|
2.879
|
2.016
|
2.027
|
2.051
|
2.467
|
2.847
|
Nettomarge
|
30,02%
|
54,81%
|
55,22%
|
28,45%
|
27,44%
|
25,3%
|
27,37%
|
27,79%
|
WPA
2 |
1,130
|
2,190
|
3,300
|
2,330
|
2,340
|
2,358
|
2,841
|
3,229
|
Free Cash Flow
1 |
428
|
842,9
|
1.057
|
910,9
|
842
|
1.704
|
2.112
|
1.569
|
FCF-marge
|
15,27%
|
26,4%
|
20,27%
|
12,86%
|
11,4%
|
21,02%
|
23,43%
|
15,32%
|
Kasstroomconversie (ebitda)
|
37,81%
|
36,52%
|
27,66%
|
30,74%
|
28,55%
|
60,05%
|
63,79%
|
40,69%
|
Kasstroomconversie (nettowinst)
|
50,85%
|
48,17%
|
36,7%
|
45,18%
|
41,55%
|
83,07%
|
85,6%
|
55,11%
|
Dividend per aandeel
2 |
0,2780
|
0,3000
|
0,5000
|
0,5500
|
0,5680
|
0,5024
|
0,5942
|
0,6041
|
Datum van publicatie
|
28/02/20
|
29/03/21
|
10/03/22
|
28/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
1.819
|
1.818
|
1.776
|
3.594
|
1.812
|
1.679
|
1.805
|
1.906
|
3.711
|
1.940
|
1.734
|
1.660
|
2.087
|
2.183
|
2.272
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
|
1.356
|
654,4
|
826,5
|
906,4
|
520,1
|
581,4
|
418,2
|
480,8
|
1.599
|
713,1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operationele Marge
|
74,57%
|
36%
|
46,53%
|
25,22%
|
28,71%
|
34,62%
|
23,18%
|
25,22%
|
43,08%
|
36,77%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Resultaat voor belastingen (EBT)
1 |
1.349
|
656
|
823,9
|
1.480
|
526,1
|
588,9
|
631,1
|
968,1
|
1.599
|
715,3
|
175,7
|
-
|
537,2
|
637,4
|
787,1
|
-
|
-
|
Nettowinst (verlies)
1 |
1.093
|
518,4
|
673,6
|
1.192
|
412,7
|
411,4
|
568,5
|
819,9
|
1.388
|
491,3
|
146,9
|
-
|
417,4
|
477
|
633
|
-
|
-
|
Nettomarge
|
60,11%
|
28,52%
|
37,92%
|
33,16%
|
22,78%
|
24,5%
|
31,5%
|
43,01%
|
37,41%
|
25,33%
|
8,47%
|
-
|
20%
|
21,85%
|
27,86%
|
-
|
-
|
WPA
2 |
1,260
|
0,6000
|
0,7800
|
-
|
0,4800
|
0,4700
|
0,6600
|
0,9500
|
-
|
0,5600
|
0,1700
|
0,2700
|
0,5095
|
0,5722
|
0,7085
|
0,4200
|
0,5800
|
Dividend per aandeel
2 |
0,5000
|
-
|
-
|
-
|
-
|
0,5500
|
-
|
-
|
-
|
-
|
0,5680
|
-
|
-
|
-
|
0,4040
|
-
|
-
|
Datum van publicatie
|
10/03/22
|
26/04/22
|
25/08/22
|
25/08/22
|
25/10/22
|
28/03/23
|
25/04/23
|
25/08/23
|
25/08/23
|
27/10/23
|
28/03/24
|
25/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.109
|
10.018
|
7.762
|
5.546
|
4.452
|
6.006
|
7.800
|
9.138
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
428
|
843
|
1.057
|
911
|
842
|
1.704
|
2.112
|
1.569
|
ROE (netto-inkomsten/eigen vermogen)
|
23,7%
|
18,7%
|
16,8%
|
10,7%
|
9,95%
|
8,08%
|
8,59%
|
10,9%
|
ROA (netto-inkomsten/totale activa)
|
14,3%
|
12,9%
|
13,3%
|
7,84%
|
7,09%
|
5,15%
|
7,21%
|
7,77%
|
Totale activa
1 |
5.906
|
13.519
|
21.624
|
25.715
|
28.564
|
39.790
|
34.218
|
36.631
|
Nettoactief per aandeel
2 |
5,640
|
18,50
|
20,80
|
22,40
|
24,10
|
26,80
|
29,30
|
32,00
|
Cashflow per aandeel
2 |
0,7000
|
1,140
|
1,630
|
1,560
|
1,320
|
2,820
|
2,390
|
3,170
|
Capex
1 |
99,5
|
156
|
367
|
447
|
308
|
699
|
407
|
394
|
Capex/omzet
|
3,55%
|
4,88%
|
7,04%
|
6,3%
|
4,18%
|
8,62%
|
4,19%
|
3,54%
|
Datum van publicatie
|
28/02/20
|
29/03/21
|
10/03/22
|
28/03/23
|
28/03/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
50,82
CNY Gemiddelde koersdoel
74,23
CNY Spread / Gemiddelde doel +46,07% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +34,14% | 51,12 mld. | | -6,54% | 39,4 mld. | | +34,92% | 38,48 mld. | | +12,62% | 26,36 mld. | | -12,11% | 26,22 mld. | | -13,43% | 20,96 mld. | | +43,73% | 14,02 mld. | | +31,81% | 12,49 mld. | | -4,54% | 11,61 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|